# Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage

> **NCT00978822** · PHASE2 · TERMINATED · sponsor: **Henry Ford Health System** · enrollment: 5 (actual)

## Conditions studied

- Subarachnoid Hemorrhage
- Hypertension

## Interventions

- **DRUG:** Clevidipine butyrate injectable emulsion

## Key facts

- **NCT ID:** NCT00978822
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2012-11
- **Final completion:** 2012-12
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Difficult enrollment parameters, subsequently low enrollment. Decision to terminate trial.
- **Last updated:** 2023-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00978822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00978822, "Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00978822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*